InVivo Therapeutics CorpのIPO年
InVivo Therapeutics CorpのIPO年は何ですか。
InVivo Therapeutics Holdings CorpのIPO年は2010です。
IPO年の定義は何ですか。
新規公開株 (IPO)は、企業の株式を通常は機関投資家に販売し、順番に証券取引所で一般市民に販売する株式公開の一種です。
Through IPO a privately held company transforms into a public company. Initial public offerings are mostly used by companies to raise the expansion of capital, possibly to monetize the investments of early private investors, and to become publicly traded enterprises. A company selling shares is never required to repay the capital to its public investors. After the IPO, when shares trade freely in the open market, money passes between public investors.
Although IPO offers many advantages, there are also significant disadvantages, chief among these are the costs associated with the process and the requirement to disclose certain information that could prove helpful to competitors.
The IPO process is colloquially known as going public. Details of the proposed offering are disclosed to potential purchasers in the form of a lengthy document known as a prospectus. Most companies undertake an IPO with the assistance of an investment banking firm acting in the capacity of an underwriter. Underwriters provide several services, including help with correctly assessing the value of shares.
NASDAQのセクタHealth CareにおけるIPO年の企業と比べるInVivo Therapeutics Corp
InVivo Therapeutics Corpは何をしますか。
about invivo therapeutics invivo therapeutics holdings corp. is a research and clinical-stage biomaterials and biotechnology company with a focus on treatment of spinal cord injuries. the company was founded in 2005 with proprietary technology co-invented by robert langer, sc.d., professor at massachusetts institute of technology, and joseph p. vacanti, m.d., who then was at boston children’s hospital and who now is affiliated with massachusetts general hospital. in 2011, the company earned the david s. apple award from the american spinal injury association for its outstanding contribution to spinal cord injury medicine. in 2015, the company’s investigational neuro-spinal scaffold received the 2015 becker’s healthcare spine device award. the publicly-traded company is headquartered in cambridge, ma. for more details, visit www.invivotherapeutics.com. about the neuro-spinal scaffold™ following acute spinal cord injury, surgical implantation of the biodegradable neuro-spinal scaffold wi
InVivo Therapeutics Corpと類似のipo年
- ChigoのIPO年は2009です。
- Jade Road InvestmentsのIPO年は2009です。
- Equity MetalsのIPO年は2009です。
- Kerr MinesのIPO年は2009です。
- China e-Wallet PaymentのIPO年は2009です。
- SQS India BFSIのIPO年は2009です。
- InVivo Therapeutics CorpのIPO年は2010です。
- Broken Hill ProspectingのIPO年は2011です。
- Apollo Global Management IncのIPO年は2011です。
- Hipo ResourcesのIPO年は2011です。
- Cogra 48 SAのIPO年は2011です。
- New Mountain Finance CorpのIPO年は2011です。
- Marfrig Global Foods SAのIPO年は2011です。